Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("VAN RIEL, P. L")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 145

  • Page / 6
Export

Selection :

  • and

Combination of second-line antirheumatic drugs : Special section: Paediatric rheumatologyHAAGSMA, C. J; VAN RIEL, P. L. C. M.Annals of medicine (Helsinki). 1997, Vol 29, Num 2, pp 169-173, issn 0785-3890Article

Management of adverse effects of disease-modifying antirheumatic drugsWIJNANDS, M. J. H; VAN RIEL, P. L. C. M.Drug safety. 1995, Vol 13, Num 4, pp 219-227, issn 0114-5916Article

Hemolysis during low-dose sulfasalazine treatment in rheumatoid arthritis patientsWIJNANDS, M. J; NUVER-ZWART, I. H; VAN RIEL, P. L et al.Scandinavian journal of rheumatology. 1991, Vol 20, Num 1, pp 52-57, issn 0300-9742, 6 p.Article

Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteriaFRANSEN, J; CREEMERS, M. C. W; VAN RIEL, P. L. C. M et al.Rheumatology (Oxford. Print). 2004, Vol 43, Num 10, pp 1252-1255, issn 1462-0324, 4 p.Article

Markers of inflammation are negatively correlated with serum leptin in rheumatoid arthritisPOPA, C; NETEA, M. G; RADSTAKE, T. R. D. S et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 8, pp 1195-1198, issn 0003-4967, 4 p.Article

Risk factors of second-line antirheumatic drugs in rheumatoid arthritisWIJNANDS, M. J; VAN RIEL, P. L; GRIBNAU, F. W et al.Seminars in arthritis and rheumatism. 1990, Vol 19, Num 6, pp 337-352, issn 0049-0172Article

A simplified disease activity index for rheumatoid arthritis for use in clinical practiceSMOLEN, J. S; BREEDVELD, F. C; SCHIFF, M. H et al.Rheumatology (Oxford. Print). 2003, Vol 42, Num 2, pp 244-257, issn 1462-0324, 14 p.Article

Generalized urticarial eruption during azathioprine treatment for rheumatoid arthritisWIJNANDS, M. J; PERRET, C. M; VAN RIEL, P. L et al.Scandinavian journal of rheumatology. 1990, Vol 19, Num 2, pp 167-169, issn 0300-9742Article

Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquineWIJNANDS, M. J; ALLEBES, W. A; BOERBOOMS, A. M. T et al.Annals of the rheumatic diseases. 1990, Vol 49, Num 10, pp 798-800, issn 0003-4967, 3 p.Article

Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritisVAN DER HEIJDE, D. M; VAN RIEL, P. L; NUVER-ZWART, I. H et al.Lancet (British edition). 1989, Num 8646, pp 1036-1038, issn 0140-6736Article

Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice : a multicentre, cluster randomised controlled trialFRANSEN, J; MOENS, H. Bernelot; SPEYER, I et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 9, pp 1294-1298, issn 0003-4967, 5 p.Article

Refractory adult onset still's disease and hypersensitivity to non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 inhibitors : are biological agents the solution?AARNTZEN, E. H. J. G; VAN RIEL, P. L. C. M; BARRERA, P et al.Annals of the rheumatic diseases. 2005, Vol 64, Num 10, pp 1523-1524, issn 0003-4967, 2 p.Article

The Disease Activity Score and the EULAR response criteriaFRANSEN, J; VAN RIEL, P. L. C. M.Clinical and experimental rheumatology (Testo stampato). 2005, Vol 23, Num 5, pp S93-S99, issn 0392-856X, SUP39Article

Titration of infliximab treatment in rheumatoid arthritis patients based on response patternsFLENDRIE, M; CREEMERS, M. C. W; VAN RIEL, P. L. C. M et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 1, pp 146-149, issn 1462-0324, 4 p.Article

Acute rheumatic fever or post-streptococcal reactive arthritis : A clinical problem revisitedJANSEN, T. L. T. A; JANSSEN, M; VAN RIEL, P. L. C. M et al.British journal of rheumatology. 1998, Vol 37, Num 3, pp 335-340, issn 0263-7103Article

Validation of rheumatoid arthritis improvement criteria that include simplified joint countsVAN GESTEL, A. M; HAAGSMA, C. J; VAN RIEL, P. L. C. M et al.Arthritis and rheumatism. 1998, Vol 41, Num 10, pp 1845-1850, issn 0004-3591Article

Rheumatoid arthritis : new trends in therapyVAN DE PUTTE, L. B. A; VAN RIEL, P. L. C. M.Clinical and experimental rheumatology (Testo stampato). 1995, Vol 13, pp S27-S30, issn 0392-856X, SUP12Conference Paper

DAS remission cut pointsFRANSEN, J; VAN RIEL, P. L. C. M.Clinical and experimental rheumatology (Testo stampato). 2006, Vol 24, Num 6, issn 0392-856X, S29-S32, SUP43Article

Health Assessment Questionnaire modifications: is standardisation needed?ZANDBELT, M. M; WELSING, P. M. J; VAN GESTEL, A. M et al.Annals of the rheumatic diseases. 2001, Vol 60, Num 9, pp 841-845, issn 0003-4967Article

The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational studyFLENDRIE, M; CREEMERS, M. C. W; WELSING, P. M. J et al.Rheumatology (Oxford. Print). 2005, Vol 44, Num 4, pp 472-478, issn 1462-0324, 7 p.Article

A double comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazineNUVER-ZWART, I. H; VAN RIEL, P. L. C. M; VAN DE PUTTE, L. B. A et al.Annals of the rheumatic diseases. 1989, Vol 48, Num 5, pp 389-395, issn 0003-4967, 7 p.Article

Functional variants of the macrophage migration inhibitory factor do not infer risk of cardiovascular disease in rheumatoid arthritisRADSTAKE, T. R. D. J; FRANSEN, J; VAN RIEL, P. L. C. M et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 1, pp 134-135, issn 0003-4967, 2 p.Article

Fc gamma receptor mediated modulation of dendritic cells as a potential strategy in the battle against rheumatoid arthritisWENINK, M. H; VAN DEN BERG, W. B; VAN RIEL, P. L. C. M et al.Netherlands journal of medicine. 2006, Vol 64, Num 4, pp 103-108, issn 0300-2977, 6 p.Article

Dose titration using the Disease Activity Score (DAS28) in rheumatoid arthritis patients treated with anti-TNF-αDEN BROEDER, A. A; CREEMERS, M. C. W; VAN GESTEL, A. M et al.Rheumatology (Oxford. Print). 2002, Vol 41, Num 6, pp 638-642, issn 1462-0324Article

Ion-pair solid-phase extraction of cimetidine from plasma and subsequent analysis by high-performance liquid chromatographyRUSSEL, F. G. M; CREEMERS, M. C. W; YUEN TAN et al.Journal of chromatography. B, Biomedical applications. 1994, Vol 661, Num 1, pp 173-177Article

  • Page / 6